Phase 3, Open-Label Study to Characerize the Incidence and Severity of Diarrhea in Patients with Early stage HER2+ Breast Cancer Treated with Neratinib and Intensive Loperamide Prophylaxis

Type of Cancer
Breast Oncology

Site
Howell

Sponsor
PUMA

Protocol Number
PUMA-NER-1301

To Learn More Call
201-510-0910